Tillman U. Gerngross

Insider Reports History

Location
Waltham, MA
Signature
/s/ Marc Grasso, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Tillman U. Gerngross:

Company Role Class Num Shares Value Price $ Report Date Ownership
Adagio Therapeutics, Inc. Chief Executive Officer, Director, 10%+ Owner Common Stock 27,845,995 $109,991,680 $3.95 10 Aug 2021 Indirect
Alector, Inc. Director Common Stock 2,644,319 $14,702,414 $5.56 14 Jun 2023 Direct
Adagio Therapeutics, Inc. Chief Executive Officer, Director, 10%+ Owner Stock Option (Right to Buy) 175,000 30 Jan 2022 Direct
Alector, Inc. Director Stock Option (right to buy) 12,360 14 Jun 2023 Direct
Adagio Therapeutics, Inc. Chief Executive Officer, Director, 10%+ Owner Series A Preferred Stock 0 10 Aug 2021 Indirect
Adagio Therapeutics, Inc. Chief Executive Officer, Director, 10%+ Owner Series B Preferred Stock 0 10 Aug 2021 Indirect
Adagio Therapeutics, Inc. Chief Executive Officer, Director, 10%+ Owner Series C Preferred Stock 0 10 Aug 2021 Indirect

Insider Reports Filed by Tillman U. Gerngross

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ALEC Alector, Inc. 14 Jun 2023 2 $0 4 Director 15 Jun 2023, 16:04
ALEC Alector, Inc. 16 Jun 2022 2 $0 4 Director 21 Jun 2022, 19:22
IVVD Adagio Therapeutics, Inc. 30 Jan 2022 1 $0 4 Chief Executive Officer, Director, 10%+ Owner 01 Feb 2022, 17:14
IVVD Adagio Therapeutics, Inc. 10 Aug 2021 4 $0 4 Chief Executive Officer, Director, 10%+ Owner 12 Aug 2021, 21:23
IVVD Adagio Therapeutics, Inc. 05 Aug 2021 0 $0 3 Chief Executive Officer, Director, 10%+ Owner 05 Aug 2021, 21:17
ALEC Alector, Inc. 17 Jun 2021 1 $0 4 Director 22 Jun 2021, 16:39